Shanghai ShengSheng Pharma's Hong Kong IPO Prospectus Expires Tomorrow, July 13

According to Zhitong Caijing, Shanghai ShengSheng Pharma Cold Chain Technology Co., Ltd.'s Hong Kong IPO prospectus, submitted on January 13, 2026, will expire tomorrow, July 13, 2026. China International Capital Corporation and Guojin Securities (Hong Kong) served as joint sponsors. The company provides temperature-controlled supply chain solutions for pharmaceutical and life sciences sectors, with a focus on clinical trial logistics and medical product distribution.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments